Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial

Overview of attention for article published in Cardiovascular Diabetology, January 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

So far, Altmetric has seen 10 X posts from 8 X users, with an upper bound of 26,589 followers.

Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up https://t.co/2AJik3vf3v

RT @syuichiao: Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year... - PubMed - NCBI https://t…

Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year... - PubMed - NCBI https://t.co/EIsVZmdNIZ

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.